Table 3.

Effect of lung transplantation on EQ5D by age group, assigning a score of 0 to those who died

		Early	Test of trend for early change	Delayed
EQ5D (MCID = 0.06)	18–49	0.19 (0.12, 0.26)	p = 0.035	−0.02 (−0.03, −0.01)
	50–64	0.16 (0.10, 0.22)		−0.03 (−0.03, −0.02)
	65+	0.08 (0.02, 0.15)		−0.02 (−0.03, −0.01)

Adjusted for sex, diagnosis, baseline body mass index, forced expiratory volume in 1 second, six minute walk distance and Lung Allocation Score

Early: From before to 3 months after transplant Delayed: 3 months after transplant to censoring which is completion of 3-year follow-up, death, dropout, or the end of the study period, whichever came first. Effect estimates reflect average change in HRQL over the early or late time period.

COPD = Chronic Obstructive Pulmonary Disease; PAH = Pulmonary Arterial Hypertension; CF = Cystic Fibrosis; PF = Pulmonary Fibrosis; BMI = Body Mass Index; 6MWD = six-minute walk distance; FEV1 = forced expiratory capacity in 1 second; LAS = Lung Allocation Score; EQ5D = Euroqol 5D